APhA Pain Institute: The Experts Debate: Controversial Topics in Pain Management (pre-registration required)


Should naloxone be dispensed with every opioid prescription? Has limited prescribing of opioids proven effective at reducing substance use disorders? Is medical cannabis safer than opioids for pain? When is it appropriate to adapt evidence-based treatment recommendations to meet the chronic pain management needs of individual patients? Are prescription drug monitoring programs effective in decreasing overdose deaths?

For pharmacists, the answers aren’t always black and white. Come to this session to hear experts lay out their arguments on these timely topics.

Pre-registration is required; registration is open at http://elearning.pharmacist.com/products/5335/apha2019-pain-institute-innovative-approaches-to-chronic-pain .

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Explain findings from available data regarding the efficacy of limited opioid prescribing for preventing misuse and abuse.
  2. Discuss the evidence regarding the efficacy of dispensing naloxone with every opioid prescription.
  3. Describe the utility of treatment algorithms in the management of pain.
  4. Explain the findings from available data regarding the efficacy of medical cannabis as an alternative to opioids for pain management.
  5. Describe the efficacy of prescription drug monitoring programs for decreasing overdose deaths associated with diversion.
Chris Herndon, PharmD, BCACP
Southern Illinois University Edwardsville
Jake Nichols, Pharm.D., MBA
Owner & CEO
Strategic Recovery Resources
Learning Level: Level 2
Track: APhA Pain Institute
Session Time Slot(s): 
Thursday, March 21
1:00 PM - 3:00 PM
Washington State Convention Center - Room 608-609
ACPE Pharmacist: 0202-0000-19-004-L01-P
CEUs Pharmacist: 0.2
Activity Type: